| 产品名称: | CFPAC-1 |
|---|---|
| 商品货号: | TS212386 |
| Organism: | Homo sapiens, human |
| Tissue: | pancreas; derived from metastatic: liver |
| Cell Type: | Epithelial |
| Product Format: | frozen |
| Morphology: | epithelial |
| Culture Properties: | adherent |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease: | ductal adenocarcinoma; cystic fibrosis |
| Age: | 26 years |
| Gender: | male |
| Ethnicity: | Caucasian |
| Applications: | This cell line is a suitable transfection host. |
| Storage Conditions: | liquid nitrogen vapor phase |
| Karyotype: | hyperdiploid; modal number = 73; range = 65 to 75; several translocations were evident; two to three apparently normal copies of number 7 (to which the cystic fibrosis gene has been mapped) were present in every metaphase examined |
| Derivation: | This line was derived from a ductal adenocarcinoma (liver metastasis) from a patient with cystic fibrosis. |
| Clinical Data: | 26 years
Caucasian
male |
| Antigen Expression: | CA19-9 antigen, 12000 units/mL, epithelial keratins |
| Genes Expressed: | carcinoembryonic antigen (CEA), 9 ng/mL; pancreatic oncofetal antigen (POA), 28 ng/mL; adenocarcinoma associated antigen (ACAA), 5000 ng/mL; CA 19-9 antigen, 12000 units/mL; epithelial keratins |
| Cellular Products: | carcinoembryonic antigen (CEA), 9 ng/mL; pancreatic oncofetal antigen (POA), 28 ng/mL; adenocarcinoma associated antigen (ACAA), 5000 ng/mL; CA 19-9 antigen, 12000 units/mL; epithelial keratins |
| Tumorigenic: | Yes |
| Effects: | Yes, in nude mice (passage 34) |
| Comments: | The cells exhibit ion transport activities consistent with cystic fibrosis and express the product of the CF gene (cystic fibrosis transmembrane regulator, CFTR).
CFPAC-1 cells show no effect of cAMP agonists, adenyl cyclase stimulators or phosphodiesterase inhibitors on Cl- flux, but do respond to Ca++ ionophores with increase Cl- efflux.
The cells have the most common form of the CF mutation, deletion of three nucleotides resulting in the absence of phenylalanine at position 508.
CFPAC-1 cells have epithelial morphology and polarization with apical microvilli, tight junctions and gap junctions. |
| Complete Growth Medium: | The base medium for this cell line is ATCC-formulated Iscoves Modified Dulbeccos Medium, Catalog No. 30-2005. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
|
| Subculturing: | Volumes are given for a 75 cm2 flask. Increase or decrease the amount of dissociation medium needed proportionally for culture vessels of other sizes.
Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:10 is recommended
Medium Renewal: Every 2 to 3 days |
| Cryopreservation: | Freeze Medium: Complete growth medium supplemented with 5% (v/v) DMSO
Storage Temperature: Liquid nitrogen vapor phase |
| Culture Conditions: | Atmosphere: Air, 95%; carbon dioxide (CO2), 5%
Temperature: 37°C |
| STR Profile: | Amelogenin: X,Y CSF1PO: 10 D13S317: 12 D16S539: 9,11 D5S818: 10,11 D7S820: 8,10 THO1: 8 TPOX: 8 vWA: 17 |
| Population Doubling Time: | 32 hrs |
| Name of Depositor: | RA Schoumacher |
| Deposited As: | Homo sapiens |
| References: | Schoumacher RA, et al. A cystic fibrosis pancreatic adenocarcinoma cell line. Proc. Natl. Acad. Sci. USA 87: 4012-4016, 1990. PubMed: 1692630 McIntosh JC, et al. Pancreatic adenocarcinoma in a patient with cystic fibrosis. Am. J. Med. 85: 592, 1988. PubMed: 3177424 |